CTOs on the Move

Canyon House and Crescent Villa

www.canyonhouse.com

 
Canyon House and Crescent Villa is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

CC Ford Group

CC Ford Group is a Bernardsville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Savista

Savista is a prominent provider of healthcare revenue cycle management services. Savista partners with healthcare organizations to problem solve and deliver revenue cycle improvement services that enable their success, support their patients, and nurture their communities. We integrate knowledge and expertise of the revenue cycle to provide financial and operational performance benefits for healthcare organizations of any size. Our global organization of 4,000 colleagues partners with more than 330 US-based healthcare clients, delivering custom solutions to help solve their business challenges.

Huupe

Founded in 2016, Huupe is the first-ever smart basketball hoop. It brings competition and training to basketball enthusiasts and players, including NBA athletes as well as stars from the league who have invested in the company. Huupe`s groundbreaking innovation enables ages eight and up to compete on the court or virtually, learn and improve their skills, track their progress, and more. The appointment of Paul as CTO follows the company`s 400% growth month over month in the past six months this year, with 50% growth in October 2022 alone, and viral popularity on social media.

East Central Health

East Central Health is a Tofield, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Menlo Therapeutics

We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.